• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Panacea Biotec Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12420.0
  • ISIN : INE922B01023
372.60 -2 (-0.57%)
  • As on 27 Sep 2026 (EOD)

  • Today’s Low

    366.00

  • Today’s High

    378.00

  • Open

    374.70

  • Perv Close

    374.75

  • 52W Low

    292.40

  • 52W High

    647.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,282.20

  • Div & Yield %

    0.00

  • Book Value(₹)

    43.03

  • Debt-Equity Ratio

    -0.57

  • AGM Date

    25-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    2,282.20

  • RONW (%)

    -4.07

  • ROCE (%)

    -3.34

Score Board

  • Equity (₹ in Cr.)

    6.13

  • BV (₹)

    43.00

  • Sales( ₹ in Cr.)

    413.49

  • NP (in Cr.)

    -29.91

  • NP Var(%)

    -96.0

  • Div%

    0.0

  • CPS (₹)

    -1.80

  • EPS (₹)

    -4.90

  • Traded Value (₹ in Lakhs)

    2,280.98

  • 52 Week High

    647.00

  • 52 Week Low

    292.40

  • Price BSE

    372.0

  • Price NSE

    373.00

  • Market Capital( in Cr.)

    2,280.98

  • P/C Ratio

    -204.10

  • P/E Ratio

    -76.20

  • Price Vs.BV

    -4.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 413.49 309.86 359.60 257.07 235.50 343.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 413.49 309.86 359.60 257.07 235.50 343.56
Other Income 18.00 16.62 24.91 34.44 12.57 20.75
Stock Adjustments 12.42 23.06 -17.79 -31.15 60.95 -14.24
Total Income 443.91 349.54 366.72 260.36 309.02 350.07
EXPENDITURE :            
Raw Materials 223.51 125.76 123.90 131.91 173.04 162.02
Power and Fuel Cost 26.43 28.46 25.33 22.43 26.51 20.78
Employee Cost 100.33 97.02 86.53 71.03 72.50 59.47
Other Manufacturing Expenses 37.90 41.12 48.20 36.31 40.76 45.75
Selling and Administration Expenses 39.67 36.34 29.99 23.41 45.82 30.87
Miscellaneous Expenses 15.91 11.14 13.71 3.45 10.51 9.97
Employee Benefit Expenses 100.33 97.02 86.53 71.03 72.50 59.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 443.75 339.84 327.65 288.54 369.13 328.85
Operating Profit 0.18 9.69 39.07 -28.20 -60.11 21.21
Interest 25.31 15.46 13.78 10.06 7.04 7.52
Gross Profit -25.13 -5.77 25.29 -38.26 -67.15 13.69
Depreciation 18.75 20.29 21.09 24.50 26.43 26.57
Profit Before Tax -43.88 -26.06 4.20 -62.76 -93.58 -12.88
Current Tax -1.59 0.00 0.64 0.00 0.00 2.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -12.38 -10.83 0.02 24.79 0.00 -0.71
Reported Net Profit -29.91 -15.23 3.55 -87.54 -93.58 -14.44
Extraordinary Items 0.00 0.06 0.05 5.30 0.01 3.26
Adjusted Net Profit -29.91 -15.29 3.50 -92.84 -93.59 -17.70
Adjustment below Net Profit 1.15 0.05 -0.06 -1.90 0.50 1.38
P & L Balance brought forward -189.08 -173.91 -177.40 -87.96 5.12 18.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -217.84 -189.08 -173.91 -177.40 -87.96 5.12
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -4.88 -2.49 0.58 -14.29 -15.28 -2.36
Earnings Per Share(Adj)-Unit Curr -4.88 -2.49 0.58 -14.29 -15.28 -2.36
Book Value 43.03 47.72 50.20 49.63 64.24 79.43
Book Value(Adj)-Unit Curr 43.03 47.72 50.20 49.63 64.24 79.43

Shareholding Pattern

  • Promoter Group

    72.48%

  • Public Share Holding

    27.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 42,080,736 68.70 42,080,736 5
Partnership Firms-Indian (Promoter & Group) 2,313,454 3.78 2,313,454 2
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 44,394,190 72.48 44,394,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,414,208 2.31 1,414,208 16
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 679 0.00 679 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,380,221 2.25 1,380,221 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,795,108 4.56 2,795,108 28
2] Non Institution
Bodies Corporate 1,110,264 1.81 1,110,264 234
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 728,058 1.19 728,058 537
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 843,563 1.38 843,563 627
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 560,484 0.92 560,484 1
Individuals holding nominal share capital up to Rs. 1 lakh 8,956,518 14.62 8,811,298 32,026
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 155,823 0.25 155,823 14
Others 98,173 0.16 98,173 2
Sub Total 14,061,448 22.96 13,916,228 33,497
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,250,746 100.00 61,105,526 33,532

Company Background

Panacea Biotec LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Panacea Biotec Ltd
  • BSE Code : 12420.0
  • ISIN : INE922B01023

  • Incorporation Year

    1984

  • Registered Office

    Ambala-Chandigarh Highway
    , Lalru,
    Punjab-140501

  • Telephone

    91-1762-505900

  • FAX

  • Chairman

    Rajesh Jain

  • Managing Director

    Ravinder Jain

  • Company Secretary

  • Auditor

    Suresh Surana & Associates LLP/R & D

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Panacea Biotec Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Panacea Biotec 372.40 431.50 413.49 -104.61 0.00
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77